ZA200800398B - Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells - Google Patents
Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cellsInfo
- Publication number
- ZA200800398B ZA200800398B ZA200800398A ZA200800398A ZA200800398B ZA 200800398 B ZA200800398 B ZA 200800398B ZA 200800398 A ZA200800398 A ZA 200800398A ZA 200800398 A ZA200800398 A ZA 200800398A ZA 200800398 B ZA200800398 B ZA 200800398B
- Authority
- ZA
- South Africa
- Prior art keywords
- muscle
- decreasing
- catabolism
- downregulation
- dietary supplement
- Prior art date
Links
- 230000015556 catabolic process Effects 0.000 title 2
- 230000003247 decreasing effect Effects 0.000 title 2
- 102000008934 Muscle Proteins Human genes 0.000 title 1
- 108010074084 Muscle Proteins Proteins 0.000 title 1
- 235000015872 dietary supplement Nutrition 0.000 title 1
- 230000003828 downregulation Effects 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 210000003205 muscle Anatomy 0.000 title 1
- 210000000663 muscle cell Anatomy 0.000 title 1
- 230000037361 pathway Effects 0.000 title 1
- 230000017854 proteolysis Effects 0.000 title 1
- 210000002027 skeletal muscle Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69740605P | 2005-07-07 | 2005-07-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200800398B true ZA200800398B (en) | 2008-12-31 |
Family
ID=37625931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200800398A ZA200800398B (en) | 2005-07-07 | 2008-01-14 | Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
Country Status (6)
Country | Link |
---|---|
US (1) | US20070015686A1 (fr) |
EP (1) | EP1904070A4 (fr) |
AU (1) | AU2006269779A1 (fr) |
CA (1) | CA2551622A1 (fr) |
WO (1) | WO2007006135A1 (fr) |
ZA (1) | ZA200800398B (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101978958A (zh) * | 2005-10-14 | 2011-02-23 | 帝斯曼知识产权资产管理有限公司 | 用于治疗肌肉消瘦的营养药物性组合物 |
WO2007133673A2 (fr) * | 2006-05-11 | 2007-11-22 | Avicena Group, Inc. | Procédés de traitement d'un trouble neurologique avec du monohydrate de créatine |
CN101484157B (zh) * | 2006-07-05 | 2012-02-29 | 花王株式会社 | 肌肉力量提高剂 |
US8962678B2 (en) | 2006-07-05 | 2015-02-24 | Kao Corporation | Senescence inhibitor |
WO2009086526A2 (fr) * | 2007-12-28 | 2009-07-09 | The Salk Institute For Biological Studies | Méthodes améliorant les performances et le tonus musculaires |
AU2007341981A1 (en) * | 2006-12-29 | 2008-07-10 | The Salk Institute For Biological Studies | Methods for enhancing exercise performance |
US7790688B2 (en) * | 2008-01-11 | 2010-09-07 | Healthspan Solutions, Llc | Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly |
US8372821B2 (en) | 2008-04-09 | 2013-02-12 | Jack H. Owoc | Stable aqueous compositions comprising bioactive creatine species |
FR2938734B1 (fr) * | 2008-11-21 | 2012-07-20 | Holymark | Composition nutritive pour sportif, en particulier pour pratiquants d'une activite physique intense ou de longue duree. |
US20120171309A1 (en) * | 2009-09-08 | 2012-07-05 | Harunobu Amagase | Formulations and methods for increasing efficacies and improving flavors of formulations containing gynostemma plant |
EP2327316B1 (fr) * | 2009-11-29 | 2016-11-16 | Premier Nutrition Corporation | Procédé d'amélioration de la synthèse de protéines musculaires |
US10869843B2 (en) * | 2010-11-23 | 2020-12-22 | Chemi Nutra | Method for increasing muscle mass and strength |
US20180193306A1 (en) | 2012-03-23 | 2018-07-12 | Cardero Therapeutics, Inc. | Compounds and compositions for the treatment of muscular disorders and bone disorders |
EP3884937A1 (fr) * | 2012-03-23 | 2021-09-29 | Cardero Therapeutics, Inc. | Composés et compositions pour le traitement d'affections musculaires |
WO2013177458A1 (fr) * | 2012-05-23 | 2013-11-28 | Chemi Nutra | Compositions destinées à augmenter la force, la masse musculaire et la masse corporelle maigre |
MX367861B (es) * | 2012-10-04 | 2019-09-09 | Abbott Lab | Una composición nutricional para usarse en la preservación del músculo esquelético. |
US9101580B2 (en) * | 2012-12-18 | 2015-08-11 | Matthew Bennett | Compositions and methods for treating traumatic brain injury |
WO2016044272A1 (fr) * | 2014-09-16 | 2016-03-24 | Abbott Laboratories | Procédés de conservation de la force musculaire au cours d'une période d'inactivité musculaire par administration de bêta-hydroxy-bêta-méthylbutyrate et d'un extrait de thé vert |
BR112018007434A2 (pt) | 2015-10-27 | 2018-10-23 | Cytozyme Animal Nutrition Inc | composições para nutrição animal, usos e métodos relacionados |
US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
TWI804469B (zh) * | 2016-07-01 | 2023-06-11 | 美商阿爾塞斯商業集團國際有限公司 | 用於重量管理之以植物為基礎的組成物及使用方法 |
WO2021076920A1 (fr) * | 2019-10-16 | 2021-04-22 | Capsugel Belgium Nv | Procédé et composition pour augmenter la synthèse de protéines musculaires |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5676978A (en) * | 1989-02-14 | 1997-10-14 | Amira, Inc. | Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent |
CN1081827A (zh) * | 1993-05-31 | 1994-02-16 | 古丈县茶叶精制厂 | 绞股蓝茶 |
US5910308A (en) * | 1997-03-19 | 1999-06-08 | Sante International Inc. | Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis |
AU5142699A (en) * | 1998-07-31 | 2000-02-28 | Mount Sinai Hospital Corporation | Methods and compositions for increasing insulin sensitivity |
IT1306173B1 (it) * | 1999-07-23 | 2001-05-30 | Sigma Tau Healthscience Spa | Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare. |
SE9903619D0 (sv) * | 1999-10-07 | 1999-10-07 | Astacarotene Ab | Use and method of treatment |
US8697679B2 (en) * | 2003-03-07 | 2014-04-15 | N.V. Nutricia | Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
ITMI20031396A1 (it) * | 2003-07-09 | 2005-01-10 | Giuliani Spa | Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante. |
EP1863433A4 (fr) * | 2005-03-18 | 2009-09-09 | Ripped Formulations Ltd | Compositions et procedes permettant d ameliorer le metabolisme, la thermogenese et/ou la definition musculaire |
CN101978958A (zh) * | 2005-10-14 | 2011-02-23 | 帝斯曼知识产权资产管理有限公司 | 用于治疗肌肉消瘦的营养药物性组合物 |
-
2006
- 2006-07-07 EP EP06752879A patent/EP1904070A4/fr not_active Withdrawn
- 2006-07-07 WO PCT/CA2006/001110 patent/WO2007006135A1/fr active Application Filing
- 2006-07-07 CA CA002551622A patent/CA2551622A1/fr not_active Abandoned
- 2006-07-07 AU AU2006269779A patent/AU2006269779A1/en not_active Abandoned
- 2006-07-07 US US11/482,485 patent/US20070015686A1/en not_active Abandoned
-
2008
- 2008-01-14 ZA ZA200800398A patent/ZA200800398B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1904070A1 (fr) | 2008-04-02 |
AU2006269779A1 (en) | 2007-01-18 |
WO2007006135A1 (fr) | 2007-01-18 |
CA2551622A1 (fr) | 2007-01-07 |
US20070015686A1 (en) | 2007-01-18 |
EP1904070A4 (fr) | 2009-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200800398B (en) | Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells | |
IL248917A0 (en) | Human anti-23-il antibodies, preparations, methods and uses | |
IL189079A0 (en) | Method of encapsulating therapeutic substances in cells | |
IL173389A0 (en) | Bone separator | |
IL186928A0 (en) | Polar lipids mixture, their preparation and uses | |
IL181335A0 (en) | Sealed pack of ingredients for an individual smoothie, and associated methods and apparatuses | |
TWI350286B (en) | Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy | |
IL183035A0 (en) | Selection of host cells expressing protein at high levels | |
GB2432039B (en) | Improvements relating to ion implantation | |
TWI316307B (en) | Case for batteries and preparation method thereof | |
IL211089A0 (en) | Compositions and methods for cell killing | |
EP1868679A4 (fr) | Therapie exercant des effets non immediats | |
EP1871793A4 (fr) | Protooncogène humain et protéine codée par celui-ci | |
IL188521A0 (en) | Compositions and methods for protein deaggregation | |
EP2086333A4 (fr) | Populations cellulaires de type myéloïde isolées et procédés de traitement avec celles-ci | |
GB2429711B (en) | Heart and skeletal muscle inflammation (HSMI) virus | |
EP1937294A4 (fr) | Protéines thérapeutiques glycolées et glycosylées dérivées de volaille | |
EP1869170A4 (fr) | Populations isolees de cellules de moelle osseuse de type myeloide et methodes de traitement correspondantes | |
GB0426182D0 (en) | Photoporation of cells | |
IL186307A0 (en) | Human glp-1 mimetibodies, compositions, methods and uses | |
GB2412585B (en) | Muscle treatment | |
GB0518582D0 (en) | Fixing member for muscle stimulating electrode, and electrode | |
ZA200708735B (en) | Supplemental dietary composition for increasing muscle size and strength | |
GB0426936D0 (en) | Inline skate | |
TW595323U (en) | Improved structure of shoe-sole |